Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Extracellular Particles Derived From Mesenchymal Stromal Cells Reduce Pseudomonas Aeruginosa Lung Infection and Inflammation in Mice

March 2025 Bioprinting, Cell Therapy, Exosomes / Extracellular Vesicles, Immunomodulation, Lung, Tissue Engineering

Rapid and Inexpensive Image-Guided Grayscale Biomaterial Customization Via LCD Printing

March 2025 Bioprinting, Bioprocessing, MedTech, Devices, & Materials, Tissue Engineering

Supercritical CO(2) With Enzymatic Posttreatment Enhances Mechanical and Biological Properties of Cancellous Bovine Bone Block Grafts

March 2025 Bioprinting, Cell Therapy, Clinical, Orthopedic, Tissue Engineering

Overexpression of Fibroblast Activation Protein (FAP) in The Stroma of Proliferative Inflammatory Atrophy (PIA) and Primary Adenocarcinoma of The Prostate

March 2025 Bioprinting, Cancer, Cell Therapy, Clinical, Immunomodulation, Tissue Engineering

Dual-mode Action of Scalable, High-Quality Engineered Stem Cell-Derived SIRPalpha-extracellular Vesicles for Treating Acute Liver Failure

February 2025 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

Mesenchymal Stem Cells‐Derived Extracellular Vesicles Mimetics as Osteoinductive Mediators for Bone Healing

February 2025 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Orthopedic, Tissue Engineering

Adapted Exosomes for Addressing Chemotherapy-induced Premature Ovarian Insufficiency

February 2025 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

3D Bioprinting Using Human Cancer and Stem Cells With Novel Arabinoxylan Bioink for 3D Cell Culture

February 2025 Bioprinting, Bioprocessing, Cancer

Perivascular Cells Function as Key Mediators of Mechanical and Structural Changes in Vascular Capillaries

January 2025 Bioprinting, Bioprocessing, Cardiovascular, Exosomes / Extracellular Vesicles, Immunomodulation, Tissue Engineering

Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor Microenvironment Model

December 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Drug Screening, Orthopedic, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 24 25 26 27 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email